Here are a few I'm looking at (all penny stocks-under %5):
1.80 USD −0.080 (4.26%)
RIGL - they have a bunch of clinical trials; they also had Pfizer pay for a trial (asthma), then drop it but let them keep the drug with the data collected
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Pullback Is a Buying Opportunity - Live Trading News
0.51 USD −0.038 (6.91%)
VTGN - VistaGen and Nuformix initially will apply Nuformix's proprietary technology platform to develop patentable new crystalline forms of AV-101 that may have superior delivery, an enhanced therapeutic profile and additional intellectual property protection. If successful, VistaGen and Nuformix will consider opportunities to extend the collaboration to other CNS therapeutic candidates with a view to unlocking additional therapeutic and commercial opportunities.
If anyone has better picks (of which I'm sure there are), please list them here (before it goes from ground to the top floors)